SEC Form 4 · accession 0001209191-17-003069
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
SBI Holdings, Inc.
10% Owner
Period of report
Dec 28, 2016
Accepted (ET)
Jan 10, 2017 · 11:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 28, 2016 | P | 204,800 | $1,735,239.23 | A | 8,232,856 | I | By SBI Incubation Co., Ltd. |
| Common StockF3,F2 | Dec 29, 2016 | P | 16,900 | $143,507.13 | A | 8,249,756 | I | By SBI Incubation Co., Ltd. |
| Common StockF4,F2 | Dec 30, 2016 | P | 2,700 | $22,970.05 | A | 8,252,456 | I | By SBI Incubation Co., Ltd. |
| Common Stock | holding | — | — | — | 6,196,869 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased at a price of 204,185,600 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
- F2These shares are held directly by SBI Incubation Co., Ltd., which is an indirect wholly-owned subsidiary of SBI Holdings, Inc. SBI Holdings, Inc. may be deemed to be the indirect beneficial owner of these securities.
- F3The shares were purchased at a price of 16,817,600 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.
- F4The shares were purchased at a price of 2,676,700 Japanese Yen. The purchase price reported above is reflected in US Dollars, based on the Mizuho TTM rate in effect on the date of purchase, rounded to the nearest whole cent.